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1. Introduction
  Ischemia-reperfusion injury (I-RI) refers to the 
pathological process of cell structure and metabolism 
impairment aggravating induced by reentry of the blood 
supply to the tissues after a period time of ischemia[1]. As 
the development of heart transplant surgery, the prevention 
and cure of myocardial I-RI has become the hot topic 
in clinical study[2]. According to WHO statistics[3], acute 
obstructive coronary artery disease is becoming the major 
cause of deaths worldwide, in the process of treatment, the 
existing operation and drug treatment of coronary artery 
Objective: To  investigate the protective effect and mechanism of lithium chloride pretreatment 
on myocardial ischemia-reperfusion injury (I-RI) in rats. Methods: A total of 60 SD rats were 
randomly divided into control group, model group, lithium chloride intervention group and 
L-arginine methyl ester + lithium chloride intervention group with 15 in each. The I-RI model 
was established in model group, the lithium chloride intervention group and L-arginine methyl 
ester + lithium chloride intervention group by method of seaming along left anterior descending 
coronary artery myocardial, control group was only opened the chest without seaming, ST-
elevation within 2 min was regarded as modeling success. Model group did not adopted any 
intervention, lithium chloride intervention group was treated with lithium chloride injection 
15 mg/kg by jugular venipuncture preoperatively, L-arginine methyl ester + lithium chloride 
intervention group was treated with intraperitoneal injection of 30 mg•kg-1•d-1 L-arginine methyl 
ester 7 d before the test, and intravenous catheter of 15 mg/kg lithium chloride preoperatively. 
The hydroxybutyric acid dehydrogenase (HBDH), creatine kinase isoenzyme (CK-MB), superoxide 
dismutase (SOD), malondialdehyde (MDA) level and nitric oxide synthase (NOS) activites were 
tested. Each large area of myocardial ischemia tissue was extracted for determination of the 
MDA content, SOD activity in tissue and serum, and morphological changes of myocardial 
tissue. Results: SOD activity was highest in lithium chloride intervention group, followed by 
L-arginine methyl ester + lithium chloride intervention group, control group and model group 
(P<0.05); SOD activity was highest in L-arginine methyl ester + lithium chloride intervention 
group intervention group, followed by lithium chloride intervention group, control group and 
model group (P<0.05). MDA content of myocardial tissue was highest in model group, followed by 
L-arginine methyl ester + lithium chloride intervention group, the lithium chloride intervention 
group and control group (P<0.05); serum MDA content was highest in L-arginine methyl ester 
+lithium chloride intervention group, followed by model group, lithium chloride intervention 
group and control group (P<0.05). Compared with the control group, serum NOS was significantly 
higher in model group, lithium chloride intervention group and L-arginine methyl ester + lithium 
chloride intervention group (P<0.05), there was no statistical difference of serum NOS activity 
between the three groups (P>0.05); HBDH and CK-MB of plasma were highest in model group, 
followed by L-arginine methyl ester + lithium chloride intervention group, lithium chloride 
intervention group and control group (P<0.05). A significantly lighter myocardial damage was 
observed microscopically in lithium chloride intervention group than that in L-arginine methyl 
ester + lithium chloride intervention group and model group. Conclusions: lithium chloride 
pretreatment can significantly reduce the myocardial I-RI, maintain structure and function of 
myocardial cells, improve the antioxidant ability of myocardial tissue, play an effective role on 
protecting myocardial I-RI. 
Fang-Jiang Li et al./Asian Pacific Journal of Tropical Medicine (2014)744-748 745
recanalization can all cause I-RI[3]. With the deepening of 
clinical research on I-RI and the development of myocardial 
protection drugs, drug pretreatment has become the main 
method of myocardial protection. Lithium is widely existed 
in the body’s bones, muscles and major organs, is one of 
the trace elements in the human body, is also the potential 
of the myocardial protective drugs. Studies have confirmed 
that[4], after a period of time, lithium chloride pretreatment 
can reduce nerve - mental symptoms of I-RI recovery 
phase in rats. Another study showed[5-7], lithium chloride 
has antiapoptotic effect on myocardial reperfusion, which 
can effectively reduce myocardial I-RI. To observe the 
protective effects and mechanism of lithium chloride on rat 
myocardial I-RI, the author selected SD rats for myocardial 
I-RI modeling after using lithium chloride pretreatment. 
2. Materials and methods 
2.1. Experimental animals
  A total of 60 healthy adult SD rats were selected, weighting 
250-300 g, male and female unlimited. They were purchased 
from Nanjing University Laboratory Animal Center, and 
provided with free food and water. 
2.2. Instrument and reagent
  Small animal breathing machine, electrocardiograph 
(Nanjing Yu’s Biotechnology Company); MICROM HM325 
tissue slicing machine (Zeiz Company, Germany); 
Spectrophotometric instrument (Olympus Company, Japan); 
BH-2 optical microscope (Olympus Company, Japan); 
MDA determination kit (MDA2003), SOD determination 
kit (GMS50002.1), anhydrous lithium chloride, L-arginine 
methyl ester, heparin injection, 2% pentobarbital sodium, 
bought from Nanjing Institute of Biological Engineering. 
2.3. model establishMENT 
  All rats had intraperitoneal injection of 2% sodium 
pentobarbital for anesthesia, followed by endotracheal 
intubation assisted mechanical ventilation. Indwelling tube 
was placed in the jugular vein. Skin incision was performed 
along the left collarbone midline between 4th rib, and 
muscle blunt separation was carried out. Pericardium was 
cut after thoracotomy; the left anterior descending coronary 
artery was along the joint of left atrium and pulmonary 
arterial cone using 6-0 prolene string. String was cut down 
after 30 min of artery blocking, blood supply was restored, 
closed chest, and appearance of ST-elevation within 2 min 
was regarded as modeling success. 
2.4. Animal grouping and pretreatment 
  A total of 60 SD rats were randomly divided into control 
group, model group, lithium chloride intervention group 
and L-arginine methyl ester + lithium chloride intervention 
group with 15 in each. The I-RI model was set up in 
model group, the lithium chloride intervention group and 
L-arginine methyl ester + lithium chloride intervention 
group by method of seaming along left anterior descending 
coronary artery myocardial. Rats in control group was only 
opened the chest without seaming, ST-elevation within
2 min was regarded as modeling success. Model group did 
not adopted any intervention, lithium chloride intervention 
group was treated with lithium chloride injection 15 mg/kg 
by jugular venipuncture preoperatively, L-arginine methyl 
ester + lithium chloride intervention group was treated 
with intraperitoneal injection of 30 mg•kg-1•d-1 L-arginine 
methyl ester 7 d before the test, and intravenous catheter of 
15 mg/kg lithium chloride preoperatively. After 240 min of 
reperfusion, venous blood was extracted and centrifuged, 
the serum was saved in freeze. After sacrificing the rats, 
ischemic ventricular wall was sheared,for REDOX index and 
morphological observation.
2.5. Biochemical index determination
  The hydroxybutyric acid dehydrogenase (HBDH), creatine 
kinase isoenzyme (CK-MB), superoxide dismutase (SOD), 
malondialdehyde (MDA) level and nitric oxide synthase 
(NOS) activites were detected. 
2.6.  Tissue morphology observation
  0.3 cm伊0.3 cm伊0.3 cm size of ischemic myocardial tissue 
was processed under conventional fixation, embedding, 
sectioning and HE staining, to observe the histomorphology 
changes of the damaged myocardium. 
2.7. Statistical analysis 
  Data were analyzed using SPSS19.0 statistical software, and 
expressed as mean依sd value. Comparison between groups 
was analyzed using single factor analysis of variance with q 
inspection, qualitative data was analyzed with 氈
2 test, and 
P<0.05 was regarded as significant difference. 
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3.  Results
3.1.  Changes of SOD activity and MDA level of myocardium 
and serum
  SOD activity of myocardium was highest in lithium chloride 
intervention group, followed by L-arginine methyl ester + 
lithium chloride intervention group, control group and model 
group (P<0.05); serum SOD activity was highest in L-arginine 
methyl ester + lithium chloride intervention group, followed 
by lithium chloride intervention group, control group and 
model group (P<0.05). MDA content of myocardial tissue 
was highest in model group, followed by L-arginine methyl 
ester + lithium chloride intervention group, the lithium 
chloride intervention group and control group (P<0.05); 
serum MDA content was highest in L-arginine methyl ester 
+lithium chloride intervention group, followed by model 
group, lithium chloride intervention group and control group 
(P<0.05), as shown in Table 1. 
3.2.  NOS, CK-MB and HBDH level
  Compared with the control group, serum NOS was 
significantly higher in model group, lithium chloride 
intervention group and L-arginine methyl ester + lithium 
chloride intervention group (P<0.05), there was no statistical 
difference of NOS activity between the three groups (P>0.05); 
HBDH and CK-MB of plasma were highest in model group, 
followed by L-arginine methyl ester + lithium chloride 
intervention group, lithium chloride intervention group and 
control group (P<0.05), as shown in Table 2. 
3.3. Tissue morphology observation 
  Control group showed no pathological changes of 
myocardial tissue; myocardial tissue of model group, lithium 
chloride intervention group and L-arginine methyl ester 
+ lithium chloride intervention group was microscopically 
showed with different degrees of pathological damage; 
Irregular cell nuclei,  hyperchromatic cytoplasm, 
inflammatory cells infiltration and myocardial fibrosis were 
observed in model group. Some irregular cell nucleus and 
fibrous degeneration were observed in Lithium chloride 
intervention group, the hyperchromatic cytoplasm was not 
obvious, inflammatory cells infiltration degree was slighter 
than that of model group. The myocardial damage degree 
of L-arginine methyl ester + lithium chloride intervention 
group were between model group and lithium chloride 
intervention group, the results are shown in Figure 1. 
Control group                                                       Model group
Lithium chloride intervention group              L-arginine methyl ester + lithium chloride
                                                                       intervention group
 
Figure 1.  Tissue morphology observation (HE伊200).
4.  Discussion 
  Myocardial I-RI refers to the pathological phenomena 
of aggravating myocardial tissue damage degree induced 
by blood supply restore after blood supply of myocardial 
tissue ischemia for a period of time. Damage of schemic 
myocardium after restore blood flow can be aggravated on 
the ultrastructure, function and the electrophysiological 
Table 1
Changes of SOD activity and MDA level in serum and myocardium.
Groups
SOD MDA
Myocardium (U/mg protein) Serum (U/mL) Myocardium (U/mg protein) Serum (U/mL)
Control group  72.10依10.34 188.27依26.92 0.86依0.17 4.15依1.34
Model group 67.25依5.36* 173.92依23.03*  2.05依0.61* 4.62依1.62*
Lithium chloride intervention group    85.51依15.92*# 205.37依21.25*#   1.31依0.23*# 3.68依0.64*#
L-arginine methyl ester + lithium chloride 
intervention group
    78.89依8.44*#△ 240.99依31.80*#△      1.70依0.35*#△ 5.36依0.65*#△
Note: *P＜0.05 compared with control group; #P＜0.05 compared with model group; △P＜0.05 compared with lithium chloride intervention 
group.
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change, which resulted in the pathological basis of 
ischemia-reperfusion injury[8]. Clinical symptoms of 
myocardial I-RI are often characterized by abnormal 
changes of reperfusion myocardial enzyme, arrhythmia and 
myocardial ultrastructure[9-12]. Studies have shown that[13], 
ischemic heart disease perioperative cardiac events is the 
important cause of perioperative death. Therefore, to prevent 
or alleviate perioperative I-RI is of great significance in the 
process of treatment. 
  Mechanism of myocardial I - RI is not fully clear. Studies 
have shown that[14-16], myocardial energy metabolism 
disorder, calcium overload and free radical, neutrophils 
and apoptosis may participate in myocardial I-RI. 
Preconditioning refers to adding damage to tissues and 
organs in advance to stimulate adaptation and tolerance of 
the body tissues against harmful events[17]. Studies have 
shown that[18-20], repeatedly, transient myocardial ischemia-
reperfusion can reduce myocardial cell damage due to 
long ischemia-reperfusion. According to the theory of the 
ischemic preconditioning protection mechanism, clinical 
used drugs as alternative ischemic stimulus in clinical 
application, in order to make the body produce medicine 
rational preadaptation, which is easy to control. Clinical use 
of inorganic lithium ion is more focused on the treatment of 
mental symptoms, recent studies have shown that[21], lithium 
salts can serve as an antioxidant to against ischemic anoxia. 
Other scholars found[22-24], lithium chloride pretreatment can 
reduce ischemia-reperfusion damage of neurons in rats, and 
can reduce the cerebral infarction volume. Therefore, the 
author carried on the study of lithium chloride pretreatment 
on myocardial I-RI. 
  In cardiac surgery, filling and began, with the oxygen 
molecules after myocardial ischemia can produce a 
large number of oxygen free radical, affecting lipid 
peroxidation of myocardial cell membrane, cell membrane 
and mitochondrial membrane, and increase membrane 
permeability, causing membrane dysfunction such as 
membrane receptors, ion channels dysfunction[16]. Studies 
have confirmed that[22,23], inhibition of oxygen free radicals, 
can reduce the I-RI. SOD is important metal antioxidant 
enzymes in the body by  damaging free radicals and 
preventing the toxic effects of oxygen, so SOD activity 
can indirectly reflect the clearance ability of oxygen free 
radicals. MDA is the final production of lipid peroxides, its 
content changes can indirectly reflect the damage severity 
of tissue cells by free radicals, and can reflect the lipid 
peroxidation degree. Therefore, these two indicators can 
reflect oxygen free radical scavenging ability and damage 
severity of tissue cells attack by free radicals. 
  This study showed that compared with model group, 
lithium chloride intervention group had higher level of 
serum SOD and NOS activity (P<0.05), lower plasma HBDH, 
MDA and CK-MB content (P<0.05), suggesting the lithium 
chloride pretreatment can reduce the attacks of free radicals 
on cell membrane lipid peroxidation, directly decrease 
the mitochondrial membrane damage, protect myocardial 
I-RI. In this study, the degree of myocardial damage in the 
lithium chloride intervention group rat model group and 
L-arginine methyl ester + lithium chloride intervention 
group were significantly reduced, also confirmed that the 
lithium chloride pretreatment can reduce myocardial I-RI 
effectively. 
  This study showed that the drug preconditioning of 
lithium chloride can strengthen the antioxidant capacity of 
myocardial tissue, reduce myocardial I-RI injury, and play 
an effective role in protecting myocardial I-RI.
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